HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
We are delighted to have taken part in Shangai for the CPHI China ! 🇨🇳
This participation allowed us to meet the industry and connect with customers and partners from the Asian pharmaceutical supply chain, to discuss the heartening future of Hyaluronic Acid (HA) and another biopolymer, Polynucleotides.
Thanks to everyone who visited our booth and made this event a success.
Looking forward to the next edition !
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.